In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Checkpoint Therapeutics Inc’s stock clocked out at $1.46, down -8.75% from its previous closing price of $1.60. In other words, the price has decreased by -$8.75 from its previous closing price. On the day, 0.76 million shares were traded. CKPT stock price reached its highest trading level at $1.63 during the session, while it also had its lowest trading level at $1.45.
Ratios:
To gain a deeper understanding of CKPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.
On January 20, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $16.Cantor Fitzgerald initiated its Overweight rating on January 20, 2021, with a $16 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 28 ’24 when Oliviero James F III sold 5,894 shares for $2.06 per share. The transaction valued at 12,142 led to the insider holds 350,836 shares of the business.
GRAY WILLIAM GARRETT sold 2,035 shares of CKPT for $4,212 on Feb 28 ’24. The Chief Financial Officer now owns 145,224 shares after completing the transaction at $2.07 per share. On Feb 01 ’24, another insider, Oliviero James F III, who serves as the CEO, President and Director of the company, sold 11,900 shares for $2.01 each. As a result, the insider received 23,919 and left with 369,680 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 52102000 and an Enterprise Value of 47173968. For the stock, the TTM Price-to-Sale (P/S) ratio is 521.07. Its current Enterprise Value per Revenue stands at 458.0.
Stock Price History:
Over the past 52 weeks, CKPT has reached a high of $3.62, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is -25.47%, while the 200-Day Moving Average is calculated to be -31.26%.
Shares Statistics:
It appears that CKPT traded 500.79K shares on average per day over the past three months and 396540 shares per day over the past ten days. A total of 35.69M shares are outstanding, with a floating share count of 30.61M. Insiders hold about 14.22% of the company’s shares, while institutions hold 13.58% stake in the company. Shares short for CKPT as of 1711584000 were 3740715 with a Short Ratio of 7.47, compared to 1709164800 on 3346887. Therefore, it implies a Short% of Shares Outstanding of 3740715 and a Short% of Float of 11.59.
Earnings Estimates
Its stock is currently analyzed by CRPT different market analysts. The consensus estimate for the next quarter is $1.36, with high estimates of $1.46 and low estimates of $96.29.
